Galenica AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Galenica Sante SA (GALE)"Galenica Sante SA stock price live, this page displays SIX GALE stock exchange data. View the GALE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Galenica Sante SA real time stock price chart below.
What Is the Galenica Sante SA Stock Price Today?
The Galenica Sante SA stock price today is 75.35.
What Is the Stock Symbol for Galenica Sante SA?
The stock symbol for Galenica Sante SA is ""GALE.""
What Stock Exchange Does Galenica Sante SA Trade On?
Galenica Sante SA is listed and trades on the Switzerland stock exchange.
Is Galenica Sante SA a Good Stock to Buy?
Determining whether Galenica Sante SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GALE quote. (ISIN: CH0360674466)"
What Is the Galenica Sante SA Stock Price Today?
The Galenica Sante SA stock price today is 75.35.
What Is the Stock Symbol for Galenica Sante SA?
The stock symbol for Galenica Sante SA is ""GALE.""
What Stock Exchange Does Galenica Sante SA Trade On?
Galenica Sante SA is listed and trades on the Switzerland stock exchange.
Is Galenica Sante SA a Good Stock to Buy?
Determining whether Galenica Sante SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GALE quote. (ISIN: CH0360674466)"
75.35
+0.15(+0.20%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.80
75.50
52 wk Range
69.30
78.15
GALE Scorecard
Full Analysis
Stock generally trades with low price volatility
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.8075.50
52 wk Range
69.3078.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GALE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
76.88
Upside
+2.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
- Galenica Sante SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galenica Sante SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galenica Sante SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galenica AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Galenica AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galenica Sante SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galenica AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galenica Sante SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galenica Sante SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Galenica Sante SA Company Profile
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data system for the healthcare market; develops management solutions for the healthcare market; group internal IT services; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
Compare GALE to Peers and Sector
Metrics to compare | GALE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGALEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.1x | 15.6x | −0.7x | |
PEG Ratio | −0.65 | 0.04 | 0.00 | |
Price/Book | 2.7x | 2.0x | 2.6x | |
Price / LTM Sales | 1.0x | 0.6x | 3.2x | |
Upside (Analyst Target) | 2.1% | 11.5% | 47.1% | |
Fair Value Upside | Unlock | 26.3% | 7.3% | Unlock |
Analysts' Recommendations
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 76.88
(+2.02% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.55
Dividend Yield
5.85%
Industry Median 1.98%
Annualized payout
4.4000
Paid unevenly
5-Years Growth
+5.29%
Growth Streak
People Also Watch
FAQ
What Is the Galenica Sante (GALE) Stock Price Today?
The Galenica Sante stock price today is 75.35
What Stock Exchange Does Galenica Sante Trade On?
Galenica Sante is listed and trades on the Switzerland stock exchange.
What Is the Stock Symbol for Galenica Sante?
The stock symbol for Galenica Sante is "GALE."
Does Galenica Sante Pay Dividends? What’s The Current Dividend Yield?
The Galenica Sante dividend yield is 1.46%.
What Is the Galenica Sante Market Cap?
As of today, Galenica Sante market cap is 3.76B.
What is Galenica Sante Earnings Per Share?
The Galenica Sante EPS is 3.55.
From a Technical Analysis Perspective, Is GALE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.